Heparin for patients with growth restricted fetus: A prospective randomized controlled trial

References

• Minior VK, Divon MY. Fetal growth restriction at term: myth or reality? Obstet Gynecol 1998;92:57–60.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002–2006.
   PubMed Web of Science ®Google Scholar
• de Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. Aust N Z J Obstet Gynaecol 2006;46:4–14.
   PubMed Web of Science ®Google Scholar
• Barker DJ. In utero programming of cardiovascular disease. Theriogenology 2000;53:555–574.
   PubMed Web of Science ®Google Scholar
• Nuyt AM. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin Sci (Lond) 2008;114:1–17.
   PubMed Web of Science ®Google Scholar
• Sullivan MC, Hawes K, Winchester SB, Miller RJ. Developmental origins theory from prematurity to adult disease. J Obstet Gynecol Neonatal Nurs 2008;37:158–164.
   Google Scholar
• Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008;32:213–218.
   PubMed Web of Science ®Google Scholar
• Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998;15:81–85.
   PubMed Web of Science ®Google Scholar
• Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996;17:387–391.
   PubMed Web of Science ®Google Scholar
• Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997;177:1395–1401.
   PubMed Web of Science ®Google Scholar
• Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997;177:57–65.
   PubMed Web of Science ®Google Scholar
• Macara L, Kingdom JC, Kaufmann P, Kohnen G, Hair J, More IA, Lyall F, Greer IA. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996;17:37–48.
   PubMed Web of Science ®Google Scholar
• Wang Z. Mechanism on modulating platelet function of activating blood circulation and removing stasis herbs. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12:567–70.
   Google Scholar
• Wu B, Liu M, Zhang S. Dan Shen agents for acute ischemic stroke. Stroke 2007;38:3095–3096.
   Google Scholar
• Zhu XX. Effect of danshan and persantin on the alteration of platelet aggregation and microcirculation in diabetics. Zhonghua Nei Ke Za Zhi 1985;24:197–199, 253.
   Google Scholar
• Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80:49–54.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao P, Xie Y, Wang S, Dai M, Jiang S. Role of placental apoptosis in fetal growth restriction. Zhonghua Fu Chan Ke Za Zhi 2002;37:721–722.
   Google Scholar
• Cohen M, Antman EM. Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes. Pharmacotherapy 2002;22:546–546.
   Google Scholar
• Antovic A, Blomback M, Bremme K, He S. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism. Blood Coagul Fibrinolysis 2002;13:181–186.
   PubMed Web of Science ®Google Scholar
• Bar J, Mashiah R, Cohen-Sacher B, Hod M, Orvieto R, Ben-Rafael Z, Lahav J. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res 2001;101:235–241.
   PubMed Web of Science ®Google Scholar
• Sun LZ, Zhao WY, Hong L, Peng T. Apoptosis gene expression profiling of placental trophoblast cells in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 2003;38:604–607.
   Google Scholar
• Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189–1192.
   PubMed Web of Science ®Google Scholar
• Hammer A, Blaschitz A, Daxbock C, Walcher W, Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am J Reprod Immunol 1999;41:41–51.
   Google Scholar
• Ganapathy R, Whitley GS, Cartwright JE, Dash PR, Thilaganathan B. Effect of heparin and fractionated heparin on trophoblast invasion. Hum Reprod 2007;22:2523–2527.
   PubMed Web of Science ®Google Scholar
• Bukowski R, Smith GC, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. FASTER Research Consortium. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ 2007;334:836–840.
   PubMed Web of Science ®Google Scholar
• Smith GC, Smith MF, McNay MB, Fleming JE. First-trimester growth and the risk of low birth weight. N Engl J Med 1998;339:1817–1822.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Peters MT, Vyas S, Rabinowitz R, Rosen DJ, Campbell S. Relation of rate of urine production to oxygen tension in small-for-gestational-age fetuses. Am J Obstet Gynecol 1990;162:387–391.
   PubMed Web of Science ®Google Scholar
• Dickey RP, Gasser RF. Ultrasound evidence for variability in the size and development of normal human embryos before the tenth post-insemination week after assisted reproductive technologies. Hum Reprod 1993;8:331–337.
   Google Scholar